Arndt is the retired Senior Vice President for Gundersen Health System and current Board of Trustees member. Prior to joining Gundersen, Arndt spent more than three decades at La Crosse-based Trane Company, where he worked in engineering, operations and executive leadership.
Farrell is the Senior Vice President of Business Services for Gundersen Health System. He is a mechanical engineer by training with more than 20 years of experience, including various leadership roles at Medtronic. He was also co-founder of FreshRealm, which was a player in disrupting traditional grocery with meal kits in the food industry.
Hajas is the Chairman of the Board for FreshRealm. He previously served as the Chief Executive Officer and Chief Investment Officer of Telluride Asset Management and was the President and Chief Operating Officer of Knight Trading Group. Prior to that, he was Co-Managing Partner of Arbitrade and Deephaven Capital Management and Partner at O’Connor & Associates (including being a Managing Director of Swiss Bank Corp. and UBS). He holds multiple degrees from Loyola University of Chicago.
Perry Hackett, Ph.D.
Director Hackett is a co-founder of RCI with 40 years of experience in animal genome engineering. He’s a Professor at the University of Minnesota and a co-founder of the Center for Genome Engineering.
David A. Largaespada, Ph.D.
Dr. Largaespada is a leading authority on mouse genetics, gene modification, cancer genes, and disease models. His expertise guides the science behind Recombinetics’ biomedical subsidiary, Surrogen. He is currently a Full Professor in two departments at the University of Minnesota, where he earned the prestigious American Cancer Society Research Professor Award in 2013. Additionally, he is Associate Director for Basic Research in the University’s Masonic Cancer Center. Dr. Largaespada has published over 135 scientific articles, many in the world’s highest-impact journals such as Science, Nature and Nature Genetics
Scott Rathgaber, M.D.
Dr. Rathgaber is the Chief Executive Officer of Gundersen Health System and a board-certified gastroenterologist. He is a fellow with the American Gastroenterological Association and a member of the American College of Gastroenterology, has cared for patients at Gundersen since 1998 and has been in leadership at Gundersen since 2005.
Justin Zenanko, C.P.A.
Zenanko is a Certified Public Accountant with extensive experience in corporate finance and startup development. He is the Co-Founder, Chief Executive Officer and Director of Synerfuse. He is the past Senior Vice President of Corporate Development of Recombinetics where he led fundraising efforts resulting in $34 million in angel funding and an additional $34 million in Series A funding in August 2018 from a strategic investor. He also holds a Bachelor of Arts degree with majors in Accounting, Economics with Emphasis in Finance, and Marketing from Simpson College and a Master of Arts in Christian Studies from Crown College.